Explore private companies that have undergone mergers or acquisitions.
Register to add companies to your watchlist and get access to bids/asks activity, last matched price and trade eligibility details.
Register| Active Market | Forge Price1 | Last Funding Round | Trade Eligibility | ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Company | Sector & Subsector | Market Activity4 |
Highest Bid | Lowest Ask | Last Matched | +/- to LFR | $ Total Bids |
$ Total Asks |
# Bids |
# Asks |
Current Price |
6-month |
1-year |
Total Funding |
Round | Date | Amount Raised |
Post-Money Valuation3 |
Price |
Key Investors | Common | Preferred | Fund | ||
| Kate Farms | Foodtech Agtech | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $192.04M | Series C | 9/19/2022 | $75M | $658.07M | $28.59 | Novo Holdings, Kaiser Permanente Ventures, Goldman Sachs, Main Street Advisors | |||||
| Mindstrong Health | Healthcare Digital Health | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $160.35M | Series C | 5/21/2020 | $100M | $703.91M | $8.01 | General Catalyst, ARCH Venture Partners, Foresite Capital, 8VC, Optum Ventures, What If Ventures | |||||
| Omniome | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $153.29M | Series C | 1/9/2020 | $60M | $511M | $4.17 | Madrone Capital Partners, ARCH Venture Partners, Decheng Capital, Domain Associates, Biomatics Capital Partners, Altitude Life Science Ventures, Nan Fung Life Sciences | |||||
| Orbital Therapeutics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $373M | Series A | 4/26/2023 | $270M | $705.88M | $1.50 | ARCH Venture Partners, Andreessen Horowitz, Newpath Partners, Abu Dhabi Growth Fund, Redmile Group, Exor N.V., Invus, Moore Strategic Ventures, iGlobe Platinum Fund Group, Casdin Capital, Agent Capital, Alexandria Venture Investments, Rellim Capital Management, Heritage Medical Systems | |||||
| Prepared | Enterprise Software Other Enterprise Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $137.22M | Series C-1 | 5/30/2025 | $71.47M | $541.38M | $11.98 | General Catalyst, Andreessen Horowitz, First Round Capital, Radical Ventures | |||||
| RayzeBio | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $795.51M | Series D | 9/13/2022 | $159.75M | $599.64M | $2.50 | Viking Global Investors, Sofinnova Investments, Wellington Management, Ally Bridge Group, Sands Capital, Laurion Capital Management, Soleus Capital | |||||
| SevOne | Enterprise Software Cloud / Networking Infrastructure | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $201.3M | Series C | 9/8/2015 | $50M | $891.05M | $13.24 | Westfield Capital Management, Bain Capital Ventures, Brookside Capital, HarbourVest Partners, VTT Ventures, Delaware Technology Park, Osage Partners | |||||
| Turbonomic | Enterprise Software Software Development | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $161.27M | Series E-4 | 11/4/2019 | $41.55M | $794.69M | $5.14 | Highland Capital Partners | |||||
| Drift | Enterprise Software Sales & Marketing / Adtech | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $143.9M | Series C-1 | 3/17/2021 | $30M | $683.42M | $6.54 | Harmony Partners | |||||
| EvolutionIQ | Fintech Insurance | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $213.77M | Series C | 7/30/2024 | $20.15M | $561.39M | $25.91 | Undisclosed Investors | |||||
| FinancialForce | Enterprise Software Business Operations | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $197.15M | Series C | 9/25/2017 | $37.15M | $718.39M | $4.77 | Undisclosed Investors | |||||
| Ionic Security | Enterprise Software Cybersecurity | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $227.07M | Series G | 4/1/2021 | $9.25M | $721.74M | $22.72 | Undisclosed Investors | |||||
| Iora Health | Healthcare Healthcare Providers & Services | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $400.14M | Series F | 2/10/2020 | $150M | $790.13M | $9.49 | Premji Invest, Cox Enterprises, Temasek, Devonshire Investors, .406 Ventures, Flare Capital Partners, Polaris Partners, Khosla Venture | |||||
| OnShape | Industrial Industrial Software | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $169.01M | Series D | 4/14/2016 | $105M | $800.19M | $3.66 | Andreessen Horowitz, New Enterprise Associates, North Bridge Venture Partners, Commonwealth Capital Ventures | |||||
| Optimizely | Enterprise Software Sales & Marketing / Adtech | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $201.02M | Series D | 6/18/2019 | $50M | $782.72M | $25.09 | Goldman Sachs Private Capital, Accenture Ventures | |||||
| Puppet | Enterprise Software Software Development | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $108.23M | Series E | 6/19/2014 | $59.98M | $750.24M | $12.24 | Cisco, Google Ventures, Kleiner Perkins Caufield & Byers, Triangle Peak Partners, True Ventures, VMware | |||||
| Quartet Health | Healthcare Digital Health | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $279.11M | Series B | 12/10/2021 | $60M | $646.74M | $11.26 | Independence, GV, Oak HC/FT | |||||
| Truebill | Fintech Personal Finance | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $84.68M | Series D | 6/1/2021 | $45M | $513.8M | $3.07 | Accel, Bessemer Venture Partners, Cota Capital, Eldridge Industries | |||||
| ActionIQ | Enterprise Software Sales & Marketing / Adtech | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $291.24M | Series C-1 | 3/23/2021 | $60.19M | $511.39M | $10.56 | March Capital Partners, FirstMark Capital, Balius Partners | |||||
| Callisto Media | Consumer & Lifestyle Media | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $168.62M | Series D | 12/1/2020 | $85.2M | $555.88M | $7.54 | G Squared | |||||
| Clutter | Consumer & Lifestyle Consumer Applications | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $297.72M | Series D | 2/20/2019 | $200M | $663.92M | $15.27 | Atomico, Fifth Wall Ventures, Four Rivers Group, GV, Sequoia Capital, SoftBank Group | |||||
| Nantero | Technology Hardware Computing Hardware | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $141.67M | Series H | 10/18/2018 | $20M | $563.68M | $8.50 | Dell Technologies Capital | |||||
| Pathway Genomics | Healthcare Biotech & Pharma | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $127.23M | Series E-1 | 1/5/2016 | $40M | $932.69M | $9.50 | International Business Machines | |||||
| Truepill | Healthcare Digital Health | Limited | $xx.xx | $xx.xx | $xx.xx | xx% | -- | -- | -- | -- | Not available | -- | -- | $929.28M | Series E-1 | 8/16/2023 | $7.49M | $541.17M | $22.68 | Undisclosed Investors | |||||
PLEASE READ THESE IMPORTANT LEGAL NOTICES & DISCLOSURES
Forge Price™ is a custom data-point calculated and disseminated by Forge Data LLC (“Forge Data”) and is a mark of Forge Data. Forge Price may rely on a very limited number of inputs in its calculation. Forge Price is prepared and disseminated solely for informational purposes. Redistribution is permitted solely with Forge’s written consent. While Forge has obtained information from sources it believes to be reliable, Forge does not perform an audit or undertake any duty of due diligence or independent verification of any information it receives. Forge does not guarantee the accuracy, completeness, timeliness, or availability of Forge Price, and are not responsible for any errors or omissions, regardless of the cause, or any results obtained from the use of Forge Price. Forge Price is derived from secondary activity on the Forge platform and other private market trading platforms, and other publicly-available datapoints collected by Forge. Forge Price is not intended to, and does not necessarily, represent the market price of any securities (I.e., the price at which you could buy or sell such securities). Neither reference to company names, nor calculation of Forge Price for a specific company, implies any affiliation between Forge and that company, any endorsement or sponsorship by Forge of any company or vice versa, or any partnership, joint venture or other commercial relationship between Forge and any company. Rights with respect to any company marks referred to herein are owned by the company. The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.
The dollar-figure and percentage displayed indicates the per share change in dollar amount and percentage since the most recent Forge Price change. Percentages are rounded to the nearest whole number.
Post-Money Valuation (valuation) represents the estimated valuation based on company-submitted Certificates of Incorporations (COIs).
Market activity indicates the level of activity for a company based on recent IOIs, secondary transactions, and pending transactions.
Sector and subsector descriptions focus primarily on the types of companies within the respective sectors and subsectors that are typically available through Forge Markets. Any sector or subsector as a whole may include companies that participate in business lines in other sectors or subsectors. Companies are classified into sectors and subsectors according to the problem(s) they seek to solve rather than the method by which the solution is delivered.